UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

ADX71441, a novel, potent and selective positive allosteric modulator of the GABAB receptor, shows efficacy in rodent models of overactive bladder

British journal of pharmacology, 2014-02, Vol.171 (4), p.995-1006

2014

Volltextzugriff (PDF)

ADX71441, a novel, potent and selective positive allosteric modulator of the GABA(B) receptor, shows efficacy in rodent models of overactive bladder

British journal of pharmacology, 2014-02, Vol.171 (4), p.995

2014

Volltextzugriff (PDF)

Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile

British journal of pharmacology, 2014-11, Vol.171 (21), p.4941

2014

Volltextzugriff (PDF)

Evaluation of peripheral versus central effects of GABAB receptor activation using a novel, positive allosteric modulator of the GABAB receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile

British journal of pharmacology, 2014-11, Vol.171 (21), p.4941-4954

2014

Volltextzugriff (PDF)

Evaluation of peripheral versus central effects of GABA sub(B) receptor activation using a novel, positive allosteric modulator of the GABA sub(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile

British journal of pharmacology, 2014-11, Vol.171 (21), p.4941-4954

2014

Volltextzugriff (PDF)

Evaluation of peripheral versus central effects of GABA B receptor activation using a novel, positive allosteric modulator of the GABA B receptor ADX 71943, a pharmacological tool compound with a fully peripheral activity profile

British journal of pharmacology, 2014-11, Vol.171 (21), p.4941-4954

2014

Volltextzugriff (PDF)

ADX 71441, a novel, potent and selective positive allosteric modulator of the GABA B receptor, shows efficacy in rodent models of overactive bladder

British journal of pharmacology, 2014-02, Vol.171 (4), p.995-1006

2014

Volltextzugriff (PDF)

ADX71441, a novel, potent and selective positive allosteric modulator of the GABA sub(B) receptor, shows efficacy in rodent models of overactive bladder

British journal of pharmacology, 2014-02, Vol.171 (4), p.995-1006

2014

Volltextzugriff (PDF)

Mutagenicity of benzyl chloride in the Salmonella/microsome mutagenesis assay depends on exposure conditions

Mutation research, 2007-09, Vol.633 (1), p.13-20

2007

Volltextzugriff (PDF)

Preclinical toxicology of Biovector ™ nanoparticles: Part II, local tolerance, genetic toxicology and pharmacokinetics

Toxicology letters, 1998-07, Vol.95, p.117-117

1998

Volltextzugriff (PDF)

Recognition of a Subregion of Human Proinsulin by Class I-Restricted T Cells in Type 1 Diabetic Patients

Proceedings of the National Academy of Sciences - PNAS, 2005-07, Vol.102 (30), p.10581-10586

2005

Volltextzugriff (PDF)

Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus

Rheumatology (Oxford, England), 2009-08, Vol.48 (8), p.953-957

2009

Volltextzugriff (PDF)

Abstract 546: Selectively targeting CD47 with bispecific antibody to efficiently eliminate mesothelin-positive solid tumors

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.546-546

2019

Volltextzugriff (PDF)

Leaders' Smiles Reflect Cultural Differences in Ideal Affect

Emotion (Washington, D.C.), 2016-03, Vol.16 (2), p.183-195

2016

Volltextzugriff (PDF)

Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies

Scandinavian Journal of Rheumatology, 2010-05, Vol.39 (3), p.247-253

2010

Volltextzugriff (PDF)

Association of the RAVER2 gene with increased susceptibility for ulcerative colitis

Human immunology, 2012-07, Vol.73 (7), p.732-735

2012

Volltextzugriff (PDF)

Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping

Genetic testing and molecular biomarkers, 2012-06, Vol.16 (6), p.482

2012

Volltextzugriff (PDF)

Spectrum of autoantibodies other than anti-desmoglein in pemphigus patients

Journal of the European Academy of Dermatology and Venereology, 2011-07, Vol.25 (7), p.774-781

2011

Volltextzugriff (PDF)

Abstract A088: Selective blockage of the innate immune checkpoint receptor CD47 on mesothelin (MSLN) positive solid tumor cells via dual targeting bispecific antibodies alters the tumor microenvironment to control tumor growth

Cancer immunology research, 2019-02, Vol.7 (2_Supplement), p.A088-A088

2019

Volltextzugriff (PDF)

HLA-DRB1/DQB1 susceptibility for autoimmune polyglandular syndrome type II and III in south of Tunisia

Annales d'endocrinologie, 2011-06, Vol.72 (3), p.232-238

2011

Volltextzugriff (PDF)

Benzylthiouracil induced ANCA-positive vasculitis: study of three cases and review of the literature

Annales d'endocrinologie, 2008-12, Vol.69 (6), p.517

2008

Volltextzugriff (PDF)

Clinical significance of antinucleosome antibodies in Tunisian systemic lupus erythematosus patients

Clinical rheumatology, 2005-06, Vol.24 (3), p.219-222

2005

Volltextzugriff (PDF)

Vascularite à anticorps anticytoplasme des polynucléaires neutrophiles induite par le benzylthiouracile : étude de trois observations et revue de la littérature

Annales d'endocrinologie, 2008-12, Vol.69 (6), p.517-522

2008

Volltextzugriff (PDF)

Pancreatic autoantibodies in Tunisian children with newly diagnosed type 1 diabetes

Pathologie biologie (Paris), 2008-05, Vol.56 (3), p.130-132

2008

Volltextzugriff (PDF)

Autoanticorps dans le lupus érythémateux systémique : profil et corrélations cliniques

Pathologie biologie (Paris), 2005-07, Vol.53 (6), p.311-317

2005

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(32)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(18)
Female
(16)
Science & Technology
(16)
Life Sciences & Biomedicine
(14)
Male
(14)
Adult
(11)
Middle Aged
(10)
Aged
(5)
Autoantibodies - Blood
(5)
Biological And Medical Sciences
(5)
Lupus Erythematosus, Systemic - Immunology
(5)
Medical Sciences
(5)
Adolescent
(4)
Child
(4)
Tunisia
(4)
Tunisia - Epidemiology
(4)
Animals
(3)
Autoimmune Diseases
(3)
Case-Control Studies
(3)
Endocrinology & Metabolism
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ADX71441, a novel, potent and selective positive allosteric modulator of the GABAB receptor, shows efficacy in rodent models of overactive bladder

ADX71441, a novel, potent and selective positive allosteric modulator of the GABA(B) receptor, shows efficacy in rodent models of overactive bladder

Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile

Evaluation of peripheral versus central effects of GABAB receptor activation using a novel, positive allosteric modulator of the GABAB receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile

Evaluation of peripheral versus central effects of GABA sub(B) receptor activation using a novel, positive allosteric modulator of the GABA sub(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile

Evaluation of peripheral versus central effects of GABA B receptor activation using a novel, positive allosteric modulator of the GABA B receptor ADX 71943, a pharmacological tool compound with a fully peripheral activity profile

ADX 71441, a novel, potent and selective positive allosteric modulator of the GABA B receptor, shows efficacy in rodent models of overactive bladder

ADX71441, a novel, potent and selective positive allosteric modulator of the GABA sub(B) receptor, shows efficacy in rodent models of overactive bladder

Mutagenicity of benzyl chloride in the Salmonella/microsome mutagenesis assay depends on exposure conditions

Preclinical toxicology of Biovector ™ nanoparticles: Part II, local tolerance, genetic toxicology and pharmacokinetics

Recognition of a Subregion of Human Proinsulin by Class I-Restricted T Cells in Type 1 Diabetic Patients

Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus

Abstract 546: Selectively targeting CD47 with bispecific antibody to efficiently eliminate mesothelin-positive solid tumors

Leaders' Smiles Reflect Cultural Differences in Ideal Affect

Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies

Association of the RAVER2 gene with increased susceptibility for ulcerative colitis

Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping

Spectrum of autoantibodies other than anti-desmoglein in pemphigus patients

Abstract A088: Selective blockage of the innate immune checkpoint receptor CD47 on mesothelin (MSLN) positive solid tumor cells via dual targeting bispecific antibodies alters the tumor microenvironment to control tumor growth

HLA-DRB1/DQB1 susceptibility for autoimmune polyglandular syndrome type II and III in south of Tunisia

Benzylthiouracil induced ANCA-positive vasculitis: study of three cases and review of the literature

Clinical significance of antinucleosome antibodies in Tunisian systemic lupus erythematosus patients

Vascularite à anticorps anticytoplasme des polynucléaires neutrophiles induite par le benzylthiouracile : étude de trois observations et revue de la littérature

Pancreatic autoantibodies in Tunisian children with newly diagnosed type 1 diabetes

Autoanticorps dans le lupus érythémateux systémique : profil et corrélations cliniques

Suchergebnisse filtern